June Jobs Data Puts Focus on Healthcare ETFs & Stocks
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 07 2025
0mins
Should l Buy OHI?
Source: NASDAQ.COM
U.S. Job Market Overview: Nonfarm payrolls increased by 147,000 in June 2025, with the unemployment rate decreasing to 4.1%, indicating labor market stability despite a slight decline in the overall labor force.
Healthcare Sector Insights: The healthcare sector added 39,000 jobs in June, with ETFs like Health Care Select Sector SPDR ETF (XLV) and iShares U.S. Healthcare Providers ETF (IHF) highlighted for potential investment opportunities amidst ongoing changes in healthcare coverage.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OHI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OHI
Wall Street analysts forecast OHI stock price to fall
9 Analyst Rating
4 Buy
5 Hold
0 Sell
Moderate Buy
Current: 46.630
Low
42.00
Averages
46.44
High
50.00
Current: 46.630
Low
42.00
Averages
46.44
High
50.00
About OHI
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through a single segment, which invests in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). Its core portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. The Company's portfolio of real estate investments includes over 1,026 healthcare facilities, located in 42 states and the United Kingdom that are operated by 87 third-party operators.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
BofA Downgrades Omega Healthcare Amid Competition and Regulatory Risks
- Rating Downgrade: BofA Securities has downgraded Omega Healthcare Investors (OHI) from Neutral to Underperform, with the price target reduced from $52 to $46, reflecting the company's vulnerability amid heightened competition and regulatory risks, which is expected to negatively impact the stock price.
- Earnings Forecast Adjustment: Analysts have lowered the FY26 AFFO estimate to a multiple of 15.0x from 16.5x, indicating a pessimistic outlook on the company's future earnings, which may lead to a decline in investor confidence.
- Acquisition Capability Weakening: Due to OHI's larger market capitalization, analysts have cut the FY26 acquisition volume assumption from $929 million to $633 million, indicating that OHI faces greater challenges in a competitive market and struggles to enhance earnings through acquisitions.
- Increased Regulatory Risks: Analysts noted that while the SNF subsector benefits from favorable demographic trends, it faces elevated regulatory and public reimbursement risks, which could pressure tenant coverage and result in downward pressure on OHI's valuation.
See More
Oversold Signals Emerge in Large-Cap Stocks
- Oversold Stock List: The Relative Strength Index (RSI) screening highlights Sysco Corporation (SYY) at the top with an RSI of 24, indicating significant oversold signals and a market capitalization of $34.11 billion, suggesting potential undervaluation and rebound opportunities.
- Sector Distribution: Following closely is Boston Scientific Corporation (BSX) with an RSI of 25 and a market cap of $93.26 billion, reflecting intense selling pressure across sectors such as healthcare and consumer staples, which may present value investment opportunities for investors.
- Other Notable Oversold Stocks: McCormick & Company (MKC), Cintas Corporation (CTAS), and Universal Health Services (UHS) rank in the top five with RSI values of 26 and 27, and market caps of $13.54 billion, $67.66 billion, and $10.93 billion respectively, highlighting their vulnerability in the current market environment.
- Market Pressure Analysis: All stocks in the top ten list maintain an RSI below 30, indicating high selling pressure across sectors including medical facilities, retail, and real estate, prompting investors to monitor these oversold stocks for potential rebound opportunities amidst market volatility.
See More
OMEGA HEALTHCARE INVESTORS, INC.: WELLS FARGO INCREASES TARGET PRICE FROM $45 TO $47
- Investment Update: Omega Healthcare Investors, Inc. has received a price target increase from Wells Fargo.
- New Price Target: The new target price is set at $47, up from the previous $45.
See More
Medical Properties Trust Faces Challenges and Opportunities
- Asset Sales and Dividend Cuts: Medical Properties Trust faced financial distress due to high leverage used for expansion, leading to asset sales and two dividend cuts, resulting in a 75% decline in stock price from its 2020 peak, highlighting the company's vulnerability in managing tenant rent payment issues.
- Improved Financial Foundation: Despite the challenging period, Medical Properties Trust has significantly improved its financial foundation through asset sales and dividend cuts, recently announcing a 12.5% dividend increase, which, although only a penny per share, symbolizes the company's belief that the worst is behind it.
- Future Outlook: With the company's financial situation improving, long-term investors may consider holding onto the stock for potential recovery over the coming years, even though a quick rebound should not be expected given the current stock price challenges.
- Tax Strategy Advice: For investors sitting on large paper losses, realizing those losses to offset gains elsewhere may be a prudent strategy, as it can reduce tax liabilities and free up capital for investment in stocks with better dividend histories.
See More
Medical Properties Trust Shows Signs of Recovery
- Financial Flexibility Issues: Medical Properties Trust faced significant financial flexibility challenges due to tenants' inability to pay rent, resulting in a roughly 75% decline in stock price from 2022 highs, raising concerns about its future viability.
- Dividend Cuts and Asset Sales: To navigate its difficulties, the REIT underwent two dividend cuts and sold some assets, albeit at a loss, but these actions have helped it gradually recover from its troubles.
- Dividend and Buyback Announcement: The REIT announced a 12.5% increase in dividends for late 2025, translating to a mere penny per share, alongside a $150 million stock buyback plan, indicating a positive outlook for the company's future.
- Investor Risk Assessment: While the dividend yield is nearly 6%, above the REIT average, the two dividend cuts may raise concerns for conservative investors about the company's stability, suggesting they might consider other more stable REIT options.
See More
Medical Properties Trust Increases Dividend Again
- Dividend Recovery Signal: Medical Properties Trust, after two dividend cuts, announced a quarterly dividend increase from $0.08 to $0.09 per share at the end of 2025, indicating a gradual recovery in financial health despite the modest increase of just one cent.
- Asset Sales and Financial Adjustments: To address issues with tenant payment capabilities, the REIT had to sell some assets and write off uncollectible rents, which, while causing short-term losses, helped improve the company's financial flexibility.
- Stock Buyback Plan: The REIT also announced a $150 million stock buyback plan aimed at boosting shareholder confidence and enhancing stock price, reflecting the company's optimistic outlook for future growth.
- Investor Confidence Rebuilding: Although the REIT's stock is down approximately 75% from its 2022 highs, investor confidence is beginning to recover as the business stabilizes, particularly with a dividend yield nearing 6%, though caution is still advised regarding risks.
See More
BofA Downgrades Omega Healthcare Amid Competition and Regulatory Risks
- Rating Downgrade: BofA Securities has downgraded Omega Healthcare Investors (OHI) from Neutral to Underperform, with the price target reduced from $52 to $46, reflecting the company's vulnerability amid heightened competition and regulatory risks, which is expected to negatively impact the stock price.
- Earnings Forecast Adjustment: Analysts have lowered the FY26 AFFO estimate to a multiple of 15.0x from 16.5x, indicating a pessimistic outlook on the company's future earnings, which may lead to a decline in investor confidence.
- Acquisition Capability Weakening: Due to OHI's larger market capitalization, analysts have cut the FY26 acquisition volume assumption from $929 million to $633 million, indicating that OHI faces greater challenges in a competitive market and struggles to enhance earnings through acquisitions.
- Increased Regulatory Risks: Analysts noted that while the SNF subsector benefits from favorable demographic trends, it faces elevated regulatory and public reimbursement risks, which could pressure tenant coverage and result in downward pressure on OHI's valuation.
See More
Oversold Signals Emerge in Large-Cap Stocks
- Oversold Stock List: The Relative Strength Index (RSI) screening highlights Sysco Corporation (SYY) at the top with an RSI of 24, indicating significant oversold signals and a market capitalization of $34.11 billion, suggesting potential undervaluation and rebound opportunities.
- Sector Distribution: Following closely is Boston Scientific Corporation (BSX) with an RSI of 25 and a market cap of $93.26 billion, reflecting intense selling pressure across sectors such as healthcare and consumer staples, which may present value investment opportunities for investors.
- Other Notable Oversold Stocks: McCormick & Company (MKC), Cintas Corporation (CTAS), and Universal Health Services (UHS) rank in the top five with RSI values of 26 and 27, and market caps of $13.54 billion, $67.66 billion, and $10.93 billion respectively, highlighting their vulnerability in the current market environment.
- Market Pressure Analysis: All stocks in the top ten list maintain an RSI below 30, indicating high selling pressure across sectors including medical facilities, retail, and real estate, prompting investors to monitor these oversold stocks for potential rebound opportunities amidst market volatility.
See More
OMEGA HEALTHCARE INVESTORS, INC.: WELLS FARGO INCREASES TARGET PRICE FROM $45 TO $47
- Investment Update: Omega Healthcare Investors, Inc. has received a price target increase from Wells Fargo.
- New Price Target: The new target price is set at $47, up from the previous $45.
See More
Medical Properties Trust Faces Challenges and Opportunities
- Asset Sales and Dividend Cuts: Medical Properties Trust faced financial distress due to high leverage used for expansion, leading to asset sales and two dividend cuts, resulting in a 75% decline in stock price from its 2020 peak, highlighting the company's vulnerability in managing tenant rent payment issues.
- Improved Financial Foundation: Despite the challenging period, Medical Properties Trust has significantly improved its financial foundation through asset sales and dividend cuts, recently announcing a 12.5% dividend increase, which, although only a penny per share, symbolizes the company's belief that the worst is behind it.
- Future Outlook: With the company's financial situation improving, long-term investors may consider holding onto the stock for potential recovery over the coming years, even though a quick rebound should not be expected given the current stock price challenges.
- Tax Strategy Advice: For investors sitting on large paper losses, realizing those losses to offset gains elsewhere may be a prudent strategy, as it can reduce tax liabilities and free up capital for investment in stocks with better dividend histories.
See More
Medical Properties Trust Shows Signs of Recovery
- Financial Flexibility Issues: Medical Properties Trust faced significant financial flexibility challenges due to tenants' inability to pay rent, resulting in a roughly 75% decline in stock price from 2022 highs, raising concerns about its future viability.
- Dividend Cuts and Asset Sales: To navigate its difficulties, the REIT underwent two dividend cuts and sold some assets, albeit at a loss, but these actions have helped it gradually recover from its troubles.
- Dividend and Buyback Announcement: The REIT announced a 12.5% increase in dividends for late 2025, translating to a mere penny per share, alongside a $150 million stock buyback plan, indicating a positive outlook for the company's future.
- Investor Risk Assessment: While the dividend yield is nearly 6%, above the REIT average, the two dividend cuts may raise concerns for conservative investors about the company's stability, suggesting they might consider other more stable REIT options.
See More
Medical Properties Trust Increases Dividend Again
- Dividend Recovery Signal: Medical Properties Trust, after two dividend cuts, announced a quarterly dividend increase from $0.08 to $0.09 per share at the end of 2025, indicating a gradual recovery in financial health despite the modest increase of just one cent.
- Asset Sales and Financial Adjustments: To address issues with tenant payment capabilities, the REIT had to sell some assets and write off uncollectible rents, which, while causing short-term losses, helped improve the company's financial flexibility.
- Stock Buyback Plan: The REIT also announced a $150 million stock buyback plan aimed at boosting shareholder confidence and enhancing stock price, reflecting the company's optimistic outlook for future growth.
- Investor Confidence Rebuilding: Although the REIT's stock is down approximately 75% from its 2022 highs, investor confidence is beginning to recover as the business stabilizes, particularly with a dividend yield nearing 6%, though caution is still advised regarding risks.
See More
